vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Red Rock Resorts, Inc. (RRR). Click either name above to swap in a different company.

Red Rock Resorts, Inc. is the larger business by last-quarter revenue ($507.3M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). Red Rock Resorts, Inc. runs the higher net margin — 16.3% vs 6.8%, a 9.5% gap on every dollar of revenue. On growth, Red Rock Resorts, Inc. posted the faster year-over-year revenue change (1.9% vs -1.7%). Over the past eight quarters, Red Rock Resorts, Inc.'s revenue compounded faster (2.1% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Wynn Resorts, Limited is an American publicly traded corporation based in Paradise, Nevada, that is a developer and operator of high-end hotels and casinos. It was founded in 2002 by former Mirage Resorts Chairman and CEO Steve Wynn and is now run by CEO Craig Billings. As of 2020, the company has developed six properties.

MD vs RRR — Head-to-Head

Bigger by revenue
RRR
RRR
1.0× larger
RRR
$507.3M
$493.8M
MD
Growing faster (revenue YoY)
RRR
RRR
+3.6% gap
RRR
1.9%
-1.7%
MD
Higher net margin
RRR
RRR
9.5% more per $
RRR
16.3%
6.8%
MD
Faster 2-yr revenue CAGR
RRR
RRR
Annualised
RRR
2.1%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MD
MD
RRR
RRR
Revenue
$493.8M
$507.3M
Net Profit
$33.7M
$82.7M
Gross Margin
Operating Margin
9.9%
28.3%
Net Margin
6.8%
16.3%
Revenue YoY
-1.7%
1.9%
Net Profit YoY
10.5%
-3.8%
EPS (diluted)
$0.40
$0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
RRR
RRR
Q1 26
$507.3M
Q4 25
$493.8M
$511.8M
Q3 25
$492.9M
$475.6M
Q2 25
$468.8M
$526.3M
Q1 25
$458.4M
$497.9M
Q4 24
$502.4M
$495.7M
Q3 24
$511.2M
$468.0M
Q2 24
$504.3M
$486.4M
Net Profit
MD
MD
RRR
RRR
Q1 26
$82.7M
Q4 25
$33.7M
$44.7M
Q3 25
$71.7M
$42.3M
Q2 25
$39.3M
$56.4M
Q1 25
$20.7M
$44.7M
Q4 24
$30.5M
$46.6M
Q3 24
$19.4M
$29.0M
Q2 24
$-153.0M
$35.7M
Operating Margin
MD
MD
RRR
RRR
Q1 26
28.3%
Q4 25
9.9%
28.1%
Q3 25
13.8%
27.6%
Q2 25
12.8%
31.9%
Q1 25
7.0%
31.0%
Q4 24
7.8%
28.7%
Q3 24
6.6%
27.9%
Q2 24
-31.3%
28.8%
Net Margin
MD
MD
RRR
RRR
Q1 26
16.3%
Q4 25
6.8%
8.7%
Q3 25
14.5%
8.9%
Q2 25
8.4%
10.7%
Q1 25
4.5%
9.0%
Q4 24
6.1%
9.4%
Q3 24
3.8%
6.2%
Q2 24
-30.3%
7.3%
EPS (diluted)
MD
MD
RRR
RRR
Q1 26
$0.73
Q4 25
$0.40
$0.74
Q3 25
$0.84
$0.68
Q2 25
$0.46
$0.95
Q1 25
$0.24
$0.75
Q4 24
$0.37
$0.78
Q3 24
$0.23
$0.48
Q2 24
$-1.84
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
RRR
RRR
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
Total Assets
$2.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
RRR
RRR
Q1 26
Q4 25
$375.2M
$142.5M
Q3 25
$340.1M
$129.8M
Q2 25
$224.7M
$145.2M
Q1 25
$99.0M
$150.6M
Q4 24
$229.9M
$164.4M
Q3 24
$103.8M
$117.5M
Q2 24
$19.4M
$136.4M
Total Debt
MD
MD
RRR
RRR
Q1 26
Q4 25
$570.5M
$3.4B
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
$3.4B
Q3 24
Q2 24
Stockholders' Equity
MD
MD
RRR
RRR
Q1 26
Q4 25
$865.9M
$208.3M
Q3 25
$890.7M
$219.6M
Q2 25
$833.8M
$203.4M
Q1 25
$789.2M
$247.1M
Q4 24
$764.9M
$215.1M
Q3 24
$732.5M
$175.5M
Q2 24
$706.5M
$159.0M
Total Assets
MD
MD
RRR
RRR
Q1 26
Q4 25
$2.2B
$4.2B
Q3 25
$2.2B
$4.1B
Q2 25
$2.1B
$4.0B
Q1 25
$2.0B
$4.1B
Q4 24
$2.2B
$4.0B
Q3 24
$2.1B
$4.0B
Q2 24
$2.0B
$4.0B
Debt / Equity
MD
MD
RRR
RRR
Q1 26
Q4 25
0.66×
16.30×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
15.84×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
RRR
RRR
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
RRR
RRR
Q1 26
Q4 25
$114.1M
$156.6M
Q3 25
$137.3M
$168.3M
Q2 25
$137.2M
$158.4M
Q1 25
$-117.5M
$126.2M
Q4 24
$133.0M
$148.2M
Q3 24
$91.8M
$131.0M
Q2 24
$107.0M
$142.5M
Free Cash Flow
MD
MD
RRR
RRR
Q1 26
Q4 25
$77.7M
Q3 25
$74.6M
Q2 25
$80.3M
Q1 25
$58.0M
Q4 24
$121.4M
Q3 24
$50.7M
Q2 24
$64.0M
FCF Margin
MD
MD
RRR
RRR
Q1 26
Q4 25
15.2%
Q3 25
15.7%
Q2 25
15.3%
Q1 25
11.6%
Q4 24
24.5%
Q3 24
10.8%
Q2 24
13.1%
Capex Intensity
MD
MD
RRR
RRR
Q1 26
Q4 25
15.4%
Q3 25
19.7%
Q2 25
14.9%
Q1 25
13.7%
Q4 24
5.4%
Q3 24
17.2%
Q2 24
16.2%
Cash Conversion
MD
MD
RRR
RRR
Q1 26
Q4 25
3.39×
3.51×
Q3 25
1.91×
3.98×
Q2 25
3.49×
2.81×
Q1 25
-5.66×
2.82×
Q4 24
4.36×
3.18×
Q3 24
4.72×
4.53×
Q2 24
4.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

RRR
RRR

Casino$340.5M67%
Food and beverage$90.3M18%
Room$45.5M9%
Other$26.2M5%
Native American management and development fees$4.7M1%

Related Comparisons